Wuhan Createrna Science and Technology Co., Ltd
Registry sponsor category
Industry
- Other names
- Wuhan Createrna Science and Technology Co., Ltd
- Company name
- Wuhan Createrna Science and Technology Co., Ltd
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (14)
- A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function
- A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential Hypertension
- A Study of Multiple Ascending Doses MY008211A in Healthy Adults
- A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Study of Single-dose MY008211A in Healthy Adults
- Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects
- Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria
- QR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ Study
- QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension
- Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy
- Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
- Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)
- To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects